Market Overview:
The global hydralazine injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension, rising geriatric population, and growing demand for generic drugs. By type, the global hydralazine injection market is segmented into 5 vials / box and 10 vials / box. The 10 vials / box segment is expected to grow at a higher CAGR than the 5 vials / box segment during the forecast period from 2018 to 2030. By application, the global hydralazine injection market is divided into hospital, clinics, and recovery center segments.
Product Definition:
It is a medication used to treat high blood pressure. It relaxes the muscles in the walls of blood vessels. This causes them to widen and allows more blood to flow through them.
5 vials / box:
5 vials/box is a form of injectable drug delivery system that contains the active pharmaceutical ingredient (API) in its liquid phase. It is widely used to deliver APIs for drugs that are administered intravenously or intramuscularly and whose oral dosage form has been determined to be unsuitable.
Global 5 vials/box, it's usage.
10 vials / box:
10 vials/box is a combination of water and salts which is used to injectable drug. It contains the same amount of salt as that of IV fluid, which helps in maintaining the electrolyte balance in human body. The drug is used for treatment for heart failure and chronic kidney disease patients along with other conditions such as renal tubular acidosis, acute renal injury, post-renal transplantation complications and others.
Application Insights:
The market is categorized based on application into hospital, clinics and recovery centers. The hospital segment dominated the global market in 2017 owing to increasing prevalence of cardiovascular diseases, which leads to a high demand for hydralazine injection. Moreover, rising number of hospitals and healthcare centers coupled with growing geriatric population across the globe has increased the demand for medicines that are used in cardiac care. In addition, increasing R&D activities by major players such as sanofi aventis; glaxoSmithKline; Pfizer; Novartis; and others are expected to fuel product demand over the forecast period.
Clinics segment is anticipated to witness significant growth over the forecast period due to increase in awareness about preventive healthcare along with rising incidences of lifestyle disorders among millennials globally. Moreover, companies such as Allergan Plc.; Alcon Laboratories Ltd.; Eye-Em Ltd.
Regional Analysis:
Asia Pacific held the largest market share of about 38.0% in 2017 owing to increasing demand for generic drugs and rising prevalence of heart failure. The region is expected to maintain its dominance during the forecast period due to growing healthcare spending, improving economic conditions, and an increase in awareness regarding treatment options for CHF. Moreover, a rise in number of patients with diabetes is also anticipated to fuel the regional market growth over the forecast period.
Europe holds a significant share as it was one of the first regions where hydralazine was approved after its launch under prescription drug scheme by National Health Services (NHS). In addition, presence of major players such as Pfizer Inc.; Mylan N.V.
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases: The increasing prevalence of hypertension and other heart diseases is one of the major growth drivers for the hydralazine injection market. According to a study by the World Health Organization (WHO), it is estimated that around 17.5 million people died from cardiovascular diseases in 2015, which accounted for 31% of all global deaths. This number is expected to increase in the coming years due to the rising incidence of lifestyle-related disorders such as obesity and diabetes mellitus. This will create a high demand for hydralazine injections as they are one of the most commonly prescribed drugs for treating hypertension and other heart conditions.
- Growing geriatric population: The growing geriatric population is another key factor driving growth in the hydralazine injection market. As people age, their risk of developing cardiovascular diseases increases significantly, making them more susceptible to its complications such as stroke or heart attack. In addition, elderly patients are also more likely to respond positively to treatment with hydralazine injections than younger patients owing to their reduced ability to compensate for circulatory problems caused by hypertension or congestive heart failure (CHF). Thus, this growing demographic segment will create significant demand for hydralazine injections in coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydralazine injection Market Research Report
By Type
5 vials / box, 10 vials / box
By Application
Hospital, Clinics, Recovery Center
By Companies
Novartis, Akorn, American Regent, Fresenius Kabi, X-Gen, SteriMax, Troikaa Pharmaceuticals, Zafa Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hydralazine injection Market Report Segments:
The global Hydralazine injection market is segmented on the basis of:
Types
5 vials / box, 10 vials / box
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Akorn
- American Regent
- Fresenius Kabi
- X-Gen
- SteriMax
- Troikaa Pharmaceuticals
- Zafa Pharmaceutical
Highlights of The Hydralazine injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5 vials / box
- 10 vials / box
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydralazine injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydralazine injection is a medication used to treat hypertension. It works by reducing the amount of blood that flows through your veins.
Some of the major companies in the hydralazine injection market are Novartis, Akorn, American Regent, Fresenius Kabi, X-Gen, SteriMax, Troikaa Pharmaceuticals, Zafa Pharmaceutical.
The hydralazine injection market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydralazine injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydralazine injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydralazine injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydralazine injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydralazine injection Market Size & Forecast, 2020-2028
4.5.1 Hydralazine injection Market Size and Y-o-Y Growth
4.5.2 Hydralazine injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 5 vials / box
5.2.2 10 vials / box
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydralazine injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydralazine injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 5 vials / box
9.6.2 10 vials / box
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 5 vials / box
10.6.2 10 vials / box
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 5 vials / box
11.6.2 10 vials / box
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 5 vials / box
12.6.2 10 vials / box
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 5 vials / box
13.6.2 10 vials / box
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydralazine injection Market: Competitive Dashboard
14.2 Global Hydralazine injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Akorn
14.3.3 American Regent
14.3.4 Fresenius Kabi
14.3.5 X-Gen
14.3.6 SteriMax
14.3.7 Troikaa Pharmaceuticals
14.3.8 Zafa Pharmaceutical
